 |
Definition of 'ImClone - IMCL'
A publicly-traded biotechnology company marketing products in the field of oncology. The company made international headlines in 2002 after ImClone's founder and CEO Sam Waksal was indicted for attempting an insider trade of the company's stock. Shortly after Waksal's indictment, "domestic diva" Martha Stewart was also indicted for insider trading of the same stock. Stewart received information from Waksal and her own broker that Waksal had been trying to dump $5 million worth of his shares in the company on insider information, and she sold her shares on the knowledge that Waksal had tried to sell his.
|
 |
Investopedia explains 'ImClone - IMCL'
Both Sam Waksal and Martha Stewart were convicted of insider trading and other crimes and were sentenced to spend time in federal prisons.
|
Search results for 'ImClone (IMCL)'
-
http://www.investopedia.com/articles/trading/04/082504.asp
... Figure 1 Imclone (IMCL) chart showing a major melt down in progress and comments by Zanger above the chart. Chart provided by www.chartpattern.com. ...
-
http://stocks.investopedia.com/stock-analysis/2008/5_Large_Volume_Stocks_For_Oct._6_Morning_HTE_PVX_IMCL.aspx
... 3,646,361. 345%. Provident Energy Trust (NYSE:PVX). 3,972,041. 325%. ImClone Systems (Nasdaq:IMCL). 7,049,570. 317%. Pengrowth Energy Trust (NYSE:PGH). 4,303,415 ...
-
http://www.investopedia.com/articles/trading/08/rectangle-formation.asp
... (Read more in Track Stock Prices With Trendlines.) ImClone Systems: an Example of a Rectangle Formation Figure 2 of ImClone Systems (IMCL) employs open-high-low ...
-
http://www.investopedia.com/ask/answers/05/SECfines.asp
... For example, when Martha Stewart sold ImClone (Nasdaq: IMCL) stock on non-public material information given to her by her broker, she was ordered to disgorge ...
-
http://stocks.investopedia.com/stock-analysis/2008/Biotech_ETFs_Under_The_Microscope_BBH_XBI_FBT.aspx
... Its top three holdings cancer drug maker Celgene (Nasdaq:CELG), cancer patient treatment provider ImClone Systems (Nasdaq:IMCL), and oral anticancer drug maker ...
|
|